McKenzie D T, Filutowicz H I, Swain S L, Dutton R W
Department of Biology (Q-063), University of California at San Diego, La Jolla 92093.
J Immunol. 1987 Oct 15;139(8):2661-8.
Murine B cell growth factor II (BCGF-II/interleukin 5) was purified from the conditioned media of the helper T cell line D10 . G4 . 1. The purification scheme consisted of sequential batch adsorption onto trimethylsilyl-controlled pore glass beads, high pressure ion exchange chromatography, and reverse phase high pressure liquid chromatography. The purified BCGF-II had a relative molecular weight of 45,000 when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing conditions. Identical analysis of BCGF-II under reducing conditions yielded a m.w. of 22,500, suggesting that native BCGF-II exists as a homodimer. The NH2-terminal amino acid sequence of the purified lymphokine was determined by automated Edman degradation. A single amino acid sequence of 24 residues was obtained that, upon comparison, was contained within the cDNA pSP6K-mTRF23 recently described as encoding murine BCGF-II/T cell-replacing factor. The NH2-terminal methionine in mature BCGF-II is found at position 21 of the amino acid sequence predicted from the cDNA pSP6K-mTRF23. This finding supports the contention of Kinashi et al. (Kinashi, T., N. Harada, E. Severinson, T. Tanabe, P. Sideras, M. Konishi, C. Azuma, A. Tominaga, S. Bergstedt-Lindqvist, M. Takahashi, F. Matsuda, Y. Yaoita, K. Takatsu, and T. Honjo. 1986. Nature 324:70) that amino acids 1-20 serve as the signal sequence for the BCGF-II gene. The ability of BCGF-II to stimulate the proliferation of the B cell lymphoma BCL1 was used to assess the potency of the lymphokine. BCGF-II at 13.5 pM induced 50% of the maximal proliferative response in the BCL1 cells; concentrations as low as 2 pM were still effective in stimulating the growth of the cells. Assuming that the amount of BCGF-II necessary to mount a 50% response in the BCL1 assay is defined as one unit of activity, then the purified BCGF-II has a specific activity of 16.5 U/ng of protein.
从小鼠辅助性T细胞系D10.G4.1的条件培养基中纯化出小鼠B细胞生长因子II(BCGF-II/白细胞介素5)。纯化方案包括依次用三甲基甲硅烷基可控孔径玻璃珠进行分批吸附、高压离子交换色谱和反相高压液相色谱。在非还原条件下通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析时,纯化的BCGF-II的相对分子量为45,000。在还原条件下对BCGF-II进行相同分析得到的分子量为22,500,这表明天然BCGF-II以同二聚体形式存在。通过自动Edman降解确定纯化的淋巴因子的NH2末端氨基酸序列。获得了一个24个残基的单一氨基酸序列,经比较,该序列包含在最近描述为编码小鼠BCGF-II/T细胞替代因子的cDNA pSP6K-mTRF23中。成熟BCGF-II中的NH2末端甲硫氨酸位于从cDNA pSP6K-mTRF23预测的氨基酸序列的第21位。这一发现支持了Kinashi等人(Kinashi, T., N. Harada, E. Severinson, T. Tanabe, P. Sideras, M. Konishi, C. Azuma, A. Tominaga, S. Bergstedt-Lindqvist, M. Takahashi, F. Matsuda, Y. Yaoita, K. Takatsu, and T. Honjo. 1986. Nature 324:70)的观点,即氨基酸1-20作为BCGF-II基因的信号序列。利用BCGF-II刺激B细胞淋巴瘤BCL1增殖的能力来评估淋巴因子的效力。13.5 pM的BCGF-II在BCL1细胞中诱导了50%的最大增殖反应;低至2 pM的浓度仍能有效刺激细胞生长。假设在BCL1测定中引发50%反应所需的BCGF-II量被定义为一个活性单位,那么纯化的BCGF-II的比活性为16.5 U/ng蛋白质。